The molecular basis of type 1von Willebrand disease.
Mohlke, Karen Lynn
1996
Abstract
Von Willebrand factor (VWF) is a plasma glycoprotein that acts as a carrier for factor VIII in the circulation and mediates both the adhesion and aggregation of platelets at sites of vessel injury, particularly under conditions of high shear. Defects in VWF result in von Willebrand disease (VWD), a common inherited bleeding disorder. In type 1 VWD, the most common VWD subtype, VWF structure is normal but plasma and/or platelet VWF levels are reduced to approximately 20-50% of normal. Inheritance of type 1 VWD is autosomal dominant with reduced penetrance and variable expression. Few molecular defects have been identified in type 1 VWD patients. This dissertation examines the molecular pathogenesis of type 1 and type 3 VWD in a pedigree and investigates the genetic basis for a mouse model of type 1 VWD. A proband with type 3 VWD is shown to be homozygous for a previously reported single nucleotide deletion in VWF exon 18, $\Delta$C2685. The phenotype in heterozygotes is observed to range from normal to type 1 VWD. Although this frameshift mutation results in proximal premature termination of VWF translation, the abnormal VWF mRNA is stable. The mutant truncated recombinant VWF protein is retained within transfected cells, and no propeptide processing is observed. Cotransfection of mutant and wild-type recombinant VWF fails to demonstrate a dominant effect of the mutant on the normal allele. The dissertation next focuses on characterization of a mouse model for type 1 VWD, the inbred mouse strain RIIIS/J. Among progeny from crosses between RIIIS/J and the PWK or CASA/Rk strains, the distributions of VWF levels suggest the presence of a major autosomal dominant gene for low VWF levels. Analysis of intragenic polymorphisms excludes the Vwf locus as a significant determinant of VWF level in RIIIS/J mice. The major novel locus, Mvwf, for modifier of VWF, maps to an approximately 0.5 centimorgan interval on chromosome 11, between nerve growth factor receptor (Ngfr) and the homeobox b (Hoxb) cluster, nonrecombinant with gastric inhibitory peptide (Gip). A contig of isolated yeast artificial chromosomes and genomic P1 clones partially cover the Mvwf region. The contig contains a glycosyltransferase, the N-acetylgalactosamine transferase Ctnac, a strong candidate for the Mvwf gene. Characterization of the human homologue of Mvwf could identify an important modifying factor for VWD penetrance and expressivity in humans. Together, these studies illustrate two fundamental mechanisms contributing to the clinical expression of type 1 VWD: inactivating mutations in the VWF gene and alterations in modifying genes that also contribute to the determination of plasma VWF level.Other Identifiers
(UMI)AAI9635575
Subjects
Biology, Molecular Biology, Genetics
Types
Thesis
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.